REVENUE - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Oct. 31, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Net contract assets		$ 600		$ 1,100
Revenue		179,410	$ 64,499
Accounts receivable, allowance for doubtful accounts		500		$ 300
Product
Disaggregation of Revenue [Line Items]
Revenue		177,454	64,499
Product | United States Department of Defense
Disaggregation of Revenue [Line Items]
Maximum percentage limit to purchase in quarterly production	45.00%
Product | Cue COVID-19 Test | United States Department of Defense
Disaggregation of Revenue [Line Items]
Agreement value	$ 480,900
Advance for scaling	184,600
Agreement value for sale of product	$ 296,300
Grant and other
Disaggregation of Revenue [Line Items]
Revenue		1,956	0
Grant and other | Biomedical Advanced Research And Development Authority (BARDA)
Disaggregation of Revenue [Line Items]
Revenue		$ 2,000	$ 0